INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 1 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $30,526,000 | +20.1% | 3,028,354 | -13.8% | 0.37% | +21.5% |
| Q2 2018 | $25,424,000 | +19.9% | 3,511,544 | 0.0% | 0.30% | +15.2% |
| Q1 2018 | $21,210,000 | -59.2% | 3,511,544 | -35.1% | 0.26% | -60.0% |
| Q4 2017 | $52,014,000 | -5.1% | 5,406,844 | -12.4% | 0.66% | +25.6% |
| Q3 2017 | $54,802,000 | -29.8% | 6,171,440 | 0.0% | 0.52% | -35.9% |
| Q2 2017 | $78,069,000 | +22.3% | 6,171,440 | +1.6% | 0.82% | +13.1% |
| Q1 2017 | $63,811,000 | +14.2% | 6,071,440 | 0.0% | 0.72% | +1.5% |
| Q4 2016 | $55,857,000 | -13.9% | 6,071,440 | +10.3% | 0.71% | -3.7% |
| Q3 2016 | $64,871,000 | +6.9% | 5,502,240 | +17.4% | 0.74% | +16.7% |
| Q2 2016 | $60,666,000 | -16.8% | 4,688,240 | +2.9% | 0.63% | -17.5% |
| Q1 2016 | $72,878,000 | -41.7% | 4,557,740 | +4.4% | 0.77% | -32.2% |
| Q4 2015 | $125,020,000 | +7.6% | 4,366,740 | +7.0% | 1.13% | -3.5% |
| Q3 2015 | $116,168,000 | +23.3% | 4,081,800 | +55.6% | 1.17% | +69.8% |
| Q2 2015 | $94,218,000 | +30.4% | 2,623,000 | +111.0% | 0.69% | +12.0% |
| Q1 2015 | $72,267,000 | +37.9% | 1,243,200 | 0.0% | 0.62% | +23.2% |
| Q4 2014 | $52,413,000 | +83.7% | 1,243,200 | +69.0% | 0.50% | +68.1% |
| Q3 2014 | $28,527,000 | – | 735,600 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 788,175 | $10,199,000 | 4.68% |
| SCOPIA CAPITAL MANAGEMENT LP | 8,987,313 | $116,296,000 | 2.40% |
| Antipodean Advisors LLC | 305,294 | $3,951,000 | 2.39% |
| Freshford Capital Management, LLC | 475,984 | $6,159,000 | 1.81% |
| Folger Hill Asset Management LP | 1,597,945 | $20,677,000 | 1.61% |
| JW Asset Management, LLC | 150,638 | $1,949,000 | 1.55% |
| 12 West Capital Management LP | 623,791 | $8,072,000 | 1.30% |
| Orbimed Advisors | 4,688,240 | $60,666,000 | 0.63% |
| CYPRESS FUNDS LLC | 135,584 | $1,754,000 | 0.41% |
| Rock Springs Capital Management LP | 365,500 | $4,730,000 | 0.35% |